Fresenius Boston-TKC — Boston, Massachusetts

Fresenius Boston-TKC is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Fresenius Boston-TKC has participated in 1 clinical trials.

Therapeutic areas: Dialysis, Cardiovascular Disease, Atherosclerosis.

Sponsors: Brigham and Women's Hospital.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fresenius Boston-TKC?

Fresenius Boston-TKC has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fresenius Boston-TKC conducted?

Fresenius Boston-TKC has 1 clinical trials on record. Their work covers Dialysis, Cardiovascular Disease, Atherosclerosis.

Is Fresenius Boston-TKC accredited by Crixeo Health?

Fresenius Boston-TKC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fresenius Boston-TKC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.